Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.05M Buy
106,964
+320
+0.3% +$25.8K 0.1% 130
2026
Q1
$7.54M Hold
106,644
0.08% 141
2025
Q4
$8.42M Hold
106,644
0.11% 114
2025
Q3
$8.78M Sell
106,644
-1,620
-1% -$127K 0.19% 95
2025
Q2
$8.71M Buy
108,264
+690
+0.6% +$53.2K 0.21% 96
2025
Q1
$8.64M Sell
107,574
-1,390
-1% -$116K 0.23% 91
2024
Q4
$8.88M Buy
108,964
+1,390
+1% +$116K 0.23% 90
2024
Q3
$8.87M Sell
107,574
-9,860
-8% -$737K 0.24% 91
2024
Q2
$8.24M Hold
117,434
0.24% 92
2024
Q1
$8.7M Buy
+117,434
New +$8.19M 0.27% 86

Other funds holding MET

Allianz's MET Position: Q2 2026 in Review

Allianz increased its MetLife (MET) stake by 0.3% in Q2 2026, buying an estimated $25.8K and bringing the position to 106,964 shares worth $9.05M. The position accounts for 0.1% of the portfolio, ranked #130.

Allianz first reported a position in MET in Q1 2024 and has held it in 10 quarters since. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Allianz held 106,964 shares of MetLife worth $9.05M as of Q2 2026.
  • Allianz bought 320 MetLife shares in Q2 2026, an estimated $25.8K.
  • MetLife made up 0.1% of Allianz's portfolio in Q2 2026, its #130 holding.
  • Allianz first reported a position in MetLife in Q1 2024 and has held it in 10 quarters since.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.